Search General Info
Search Education
Search Partnering Companies

Staci Hargraves

Staci Hargraves is Vice President of R&D Portfolio Management for Janssen, the Pharmaceutical Company of Johnson & Johnson. In this role, she is responsible for managing and driving unprecedented value across Janssen’s multi-billion dollar R&D portfolio. Recently she served as VP, R&D Strategy and Operations as well as served as the Chief of Staff for the Janssen R&D Chief Operating Officer where she ensures alignment across several R&D operational functions including Clinical Innovation, Pharmaceutical Development & Manufacturing Sciences, Quantitative Sciences, and Strategy Management, Planning & Analytics.

Prior to joining Janssen in 2017, Staci was the Sr. Director of Clinical Operations
at Regeneron Pharmaceuticals where she led a very diverse group of operational functions that that supported the organizations clinical trials.

Staci accelerated through her career by holding various supply chain related positions with increasing level of responsibilities at Pharmaceutical Product Development (PPD), UCB Pharma, and Otsuka. Staci started her career at the National Institute of Health (NIH) in the Protocol & Information Office of the National Cancer Institute.

Staci is a graduate of George Mason University, Fairfax VA where she excelled both on and off the track as a 6 Time NCAA Division I Track & Field All American. She currently resides in New Rochelle, NY with her husband Joe and their three boys (Jacob, Jordan, & Justin).

A passionate executive, Staci is active in several professional and community-based organizations. She currently the Executive Sponsor for Janssen’s Diversity in Clinical Trial efforts. She is an active member of the National Coalition of 100 Black Women (NCBW100), founder of the Diversity Council at the Iona Preparatory School and participates in several STEM programs for diverse populations.
Speaking In
4:00 PM - 4:45 PM (EDT)
Thursday, June 17

Promoting health equity and eliminating systemic inequalities in the biotech ecosystem are…